Bausch Health Cos. convinced a federal court to dismiss, for now, allegations that executives misled investors about the spin-off of Bausch + Lomb, and other corporate liabilities.

Ask about health care at a summer cookout, and you’ll likely get an earful about how drug corporations are gouging us, leaving many families to choose between buying medications or putting ...

Valeant, a company which eschews R&D for aggressive marketing and M&A, had already established itself as a rogue element within pharma in 2015. Its interest in acquiring Sprout and its drug seemed ...

There have been rumours for several months that Bausch Health (formerly Valeant Pharmaceuticals), B+L's debt-ridden parent company, which retains an 88% ownership stake in its business ...

Non-Surgical Fat Reduction MarketThe non-surgical fat reduction market is projected to grow at a CAGR of 5.6%, expanding from USD 1,700.5 million in 2024 to USD 2,932.3 million by 2034. This growth is ...

Rocket Pharmaceuticals (RCKT) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising ...

Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo The U.S. Food and Drug Administration ...

Need to identify a tablet or capsule? Use our Pill Identifier to find the name and image of an unknown prescription or over-the-counter medication. Start by entering details like pill imprint code ...

Trump backs off contesting Tennessee ban on youth transgender care at Supreme Court United Statescategory· February 7, 2025 AbbVie said on Friday that the U.S. Food and Drug Administration ...